Lisata Therapeutics, Inc (LSTA) PT Raised to $32 at Brookline Capital Markets
Tweet Send to a Friend
Brookline Capital Markets analyst Kemp Dolliver raised the price target on Lisata Therapeutics, Inc (NASDAQ: LSTA) to $32.00 (from $20.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
